Activity Summary:
Chronic obstructive pulmonary disease (COPD) remains a major global health challenge, characterized by significant unmet needs in early diagnosis, personalized management, and coordinated multidisciplinary care. Many patients continue to receive suboptimal, non-guideline-aligned treatment, often leading to poorer outcomes, increased exacerbations, and diminished quality of life.

Join Dr. Bose and Dr. Han as they present key clinical findings in COPD Management. This activity includes four modules:

1. COPD Management
2. Highlights from 2025 Conferences and Publications
3. Persistent Dyspnea Despite Guideline-based Therapy (Case Review)
4. Recurrent Exacerbations in Biomarker-defined Subgroup (Case Review)

Activity Summary:
The field of pulmonary medicine, especially in the management of interstitial lung diseases (ILD), is experiencing a vibrant era of growth with continuous advancements in diagnostic methods and treatment strategies. These progresses are transforming patient care, though the rapid pace of emerging research and the complexities involved in integrating new evidence into clinical practice present unique challenges.

These accredited slides offer key presentations, posters, and abstracts presented in Chicago from October 19-22, 2025, that have important clinical implications for advancing the care of interstitial lung disease (ILD).

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Clinical Clips will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with "what you need to know" podcast episodes from data presented at IDWeek 2025.

Activity Summary:

In this 15-minute podcast, Dr. Steven Nathan reviews clinically significant presentations, posters, and abstracts presented in Chicago from October 19-22, 2025, that offer key insights for improving the diagnosis and management of interstitial lung disease (ILD).

Activity Summary:
The field of pulmonary medicine, especially in the management of interstitial lung diseases (ILD), is experiencing a vibrant era of growth with continuous advancements in diagnostic methods and treatment strategies. These progresses are transforming patient care, though the rapid pace of emerging research and the complexities involved in integrating new evidence into clinical practice present unique challenges.

In this 15-minute video, Dr. Steven Nathan highlights key presentations, posters, and abstracts presented in Chicago from October 19-22, 2025, that have important clinical implications for advancing the care of interstitial lung disease (ILD).

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Clinical Clips will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with "what you need to know" videos from data presented at IDWeek 2025.

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Clinical Clip podcasts will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with "what you need to know" videos from data presented at EACS 2025.

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Clinical Clips will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with "what you need to know" videos from data presented at EACS 2025.

Activity Summary:

This activity will provide a comprehensive overview of NF1-PN and will dive deeper into the nuances of treating and managing adult patients with inoperable symptomatic NF1-PN. Dr. Angela Hirbe will use clinical cases to illustrate best-practice approaches to optimally identify adult patients with NF1-PN that will benefit from approved MEK inhibitors and will detail how to choose between agents and address/prevent adverse effects. The work-up and monitoring recommendations will also be discussed and any insights for achieving improved outcomes among diverse patients will be detailed. This presentation will empower participants to make informed clinical decisions for different patients with distinct needs.

Activity Summary:

This activity will provide a comprehensive overview of NF1-PN and will dive deeper into the nuances of treating and managing adult patients with inoperable symptomatic NF1-PN. Dr. Angela Hirbe will use clinical cases to illustrate best-practice approaches to optimally identify adult patients with NF1-PN that will benefit from approved MEK inhibitors and will detail how to choose between agents and address/prevent adverse effects. The work-up and monitoring recommendations will also be discussed and any insights for achieving improved outcomes among diverse patients will be detailed. This presentation will empower participants to make informed clinical decisions for different patients with distinct needs.